Study Details

Back
Study ID STCR-0802-TW
Study Title A randomized, open-label, active-control, parallel-group study to evaluate the efficacy and safety of zolpidem MR (modified release) in patients with primary insomnia.(Original language of CSR synopsis is Chinese.)
Clinicaltrials.gov Identifier NCT00956319
Compound Name FK199 / zolpidem tartrate
Medical Indication or Disease Insomnia
Study Sponsor Astellas Pharma Taiwan, Inc.
Collaborator Not Applicable
Study Start Date 12-May-2009
Study Completion Date 17-Nov-2010
Clinical Study Result
Select the language
Plain Language Summary
Select the language
Not Available

QUICK SEARCH

USEFUL LINKS